Skip to content
1st Counsel – Lifestyle
Author:
Fanttik
Diakonos Oncology Awarded Fast Track Designation by FDA for DOC1021 (dubodencel) in Unresectable or Metastatic Cutaneous Melanoma
May 7, 2026
Diakonos Oncology Reports Positive Clinical Data from Phase 1 Pancreatic Cancer Study and Expanded Access Program in Glioblastoma at AACR and AAN 2026
May 3, 2026
/C O R R E C T I O N — Diakonos Oncology/
April 1, 2026
Fanttik Launches 20+ Spring New Arrivals, Bringing Portable Power and Smarter DIY Solutions
March 18, 2026
Diakonos Oncology to Showcase DOC1021 (dubodencel) Clinical Data in Pancreatic Cancer and Glioblastoma at AACR and ANN 2026
March 18, 2026
Fanttik Spring New Arrivals in March: Powering Everyday Projects with Portable Innovation
March 11, 2026
Fanttik Launches 20+ Compact & High-Performance Tools for Spring, Targeting Home Maintenance and DIY Enthusiasts
March 10, 2026
Fanttik Spring New Arrivals in March: Powering Your Everyday Projects with Portable Innovation
March 10, 2026
Fanttik Launches 20+ Compact & High-Performance Tools for Spring, Targeting Home Maintenance and DIY Enthusiasts
March 10, 2026